Cipla Ltd Share Price – NSE /  BSE

Pharmaceuticals, Mid Cap

Cipla has classified its current Good Manufacturing Practices (cGMP) inspection of the company's manufacturing facility in Virgonagar, Bengaluru, conducted between 7 – 13 November 2024, as Voluntary Action Indicated (VAI).

Powered by Capital Market - Live News

Cipla will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary Limited, a wholly-owned subsidiary of the Company in South Africa (CMSA).

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical products.

The investment will be utilised to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries.

Powered by Capital Market - Live News

Cipla Ltd gained for a third straight session today. The stock is quoting at Rs 1456.1, up 2.26% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.42% on the day, quoting at 23261.2. The Sensex is at 76748.82, up 0.28%. Cipla Ltd has slipped around 4.77% in last one month.

Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has slipped around 8.79% in last one month and is currently quoting at 21163.9, up 0.9% on the day. The volume in the stock stood at 10.82 lakh shares today, compared to the daily average of 14.63 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1462.15, up 2.87% on the day. Cipla Ltd is up 7.78% in last one year as compared to a 7.07% spurt in NIFTY and a 19.04% spurt in the Nifty Pharma index.

The PE of the stock is 24.71 based on TTM earnings ending December 24.

Powered by Capital Market - Live News

Cipla will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary Limited, a wholly-owned subsidiary of the Company in South Africa (CMSA).

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical products.

The investment will be utilised to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries.

Powered by Capital Market - Live News

Cipla Ltd gained for a third straight session today. The stock is quoting at Rs 1456.1, up 2.26% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.42% on the day, quoting at 23261.2. The Sensex is at 76748.82, up 0.28%. Cipla Ltd has slipped around 4.77% in last one month.

Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has slipped around 8.79% in last one month and is currently quoting at 21163.9, up 0.9% on the day. The volume in the stock stood at 10.82 lakh shares today, compared to the daily average of 14.63 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1462.15, up 2.87% on the day. Cipla Ltd is up 7.78% in last one year as compared to a 7.07% spurt in NIFTY and a 19.04% spurt in the Nifty Pharma index.

The PE of the stock is 24.71 based on TTM earnings ending December 24.

Powered by Capital Market - Live News

Net profit of Cipla rose 48.74% to Rs 1570.51 crore in the quarter ended December 2024 as against Rs 1055.90 crore during the previous quarter ended December 2023. Sales rose 7.01% to Rs 6961.60 crore in the quarter ended December 2024 as against Rs 6505.66 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Cipla has classified its current Good Manufacturing Practices (cGMP) inspection of the company's manufacturing facility in Virgonagar, Bengaluru, conducted between 7 – 13 November 2024, as Voluntary Action Indicated (VAI).

Powered by Capital Market - Live News

Cipla will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary Limited, a wholly-owned subsidiary of the Company in South Africa (CMSA).

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical products.

The investment will be utilised to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries.

Powered by Capital Market - Live News

Cipla Ltd gained for a third straight session today. The stock is quoting at Rs 1456.1, up 2.26% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.42% on the day, quoting at 23261.2. The Sensex is at 76748.82, up 0.28%. Cipla Ltd has slipped around 4.77% in last one month.

Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has slipped around 8.79% in last one month and is currently quoting at 21163.9, up 0.9% on the day. The volume in the stock stood at 10.82 lakh shares today, compared to the daily average of 14.63 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1462.15, up 2.87% on the day. Cipla Ltd is up 7.78% in last one year as compared to a 7.07% spurt in NIFTY and a 19.04% spurt in the Nifty Pharma index.

The PE of the stock is 24.71 based on TTM earnings ending December 24.

Powered by Capital Market - Live News

Cipla will invest approx. ZAR 900 million in equity share capital of Cipla Medpro South Africa Proprietary Limited, a wholly-owned subsidiary of the Company in South Africa (CMSA).

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical products.

The investment will be utilised to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries.

Powered by Capital Market - Live News

Cipla Ltd gained for a third straight session today. The stock is quoting at Rs 1456.1, up 2.26% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.42% on the day, quoting at 23261.2. The Sensex is at 76748.82, up 0.28%. Cipla Ltd has slipped around 4.77% in last one month.

Meanwhile, Nifty Pharma index of which Cipla Ltd is a constituent, has slipped around 8.79% in last one month and is currently quoting at 21163.9, up 0.9% on the day. The volume in the stock stood at 10.82 lakh shares today, compared to the daily average of 14.63 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1462.15, up 2.87% on the day. Cipla Ltd is up 7.78% in last one year as compared to a 7.07% spurt in NIFTY and a 19.04% spurt in the Nifty Pharma index.

The PE of the stock is 24.71 based on TTM earnings ending December 24.

Powered by Capital Market - Live News

Net profit of Cipla rose 48.74% to Rs 1570.51 crore in the quarter ended December 2024 as against Rs 1055.90 crore during the previous quarter ended December 2023. Sales rose 7.01% to Rs 6961.60 crore in the quarter ended December 2024 as against Rs 6505.66 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News